Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 07, 2020

SELL
$8.49 - $19.54 $84,942 - $195,497
-10,005 Closed
0 $0
Q2 2020

Jul 21, 2020

BUY
$7.44 - $11.29 $74,437 - $112,956
10,005 New
10,005 $104,000
Q1 2020

Apr 17, 2020

SELL
$6.94 - $14.22 $465,951 - $954,730
-67,140 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$7.99 - $37.6 $536,448 - $2.52 Million
67,140 New
67,140 $538,000
Q3 2019

Oct 16, 2019

SELL
$19.17 - $27.4 $427,701 - $611,321
-22,311 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$22.93 - $42.84 $511,591 - $955,803
22,311 New
22,311 $582,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.